These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20402642)

  • 21. Cyclodextrins Based Electrochemical Sensors for Biomedical and Pharmaceutical Analysis.
    Lenik J
    Curr Med Chem; 2017; 24(22):2359-2391. PubMed ID: 27978804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating Nanoscale Electrochemistry with Surface- and Tip-Enhanced Raman Spectroscopy.
    Zaleski S; Wilson AJ; Mattei M; Chen X; Goubert G; Cardinal MF; Willets KA; Van Duyne RP
    Acc Chem Res; 2016 Sep; 49(9):2023-30. PubMed ID: 27602428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From mercury to nanosensors: Past, present and the future perspective of electrochemistry in pharmaceutical and biomedical analysis.
    Ozkan SA; Uslu B
    J Pharm Biomed Anal; 2016 Oct; 130():126-140. PubMed ID: 27210510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometry imaging for drug distribution studies.
    Prideaux B; Stoeckli M
    J Proteomics; 2012 Aug; 75(16):4999-5013. PubMed ID: 22842290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoscale Electrochemical Sensor Arrays: Redox Cycling Amplification in Dual-Electrode Systems.
    Wolfrum B; Kätelhön E; Yakushenko A; Krause KJ; Adly N; Hüske M; Rinklin P
    Acc Chem Res; 2016 Sep; 49(9):2031-40. PubMed ID: 27602780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrochemical Detectors in Liquid Chromatography: Recent Trends in Pharmaceutical and Biomedical Analysis.
    Kauffmann JM; Bakirhan NK; Bozal-Palabiyik B; Uslu B; Rodriguez Gomez R; Vandeput M; Ozkan SA
    Curr Med Chem; 2018; 25(33):4050-4065. PubMed ID: 28595548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrochemistry-mass spectrometry in drug metabolism and protein research.
    Permentier HP; Bruins AP; Bischoff R
    Mini Rev Med Chem; 2008 Jan; 8(1):46-56. PubMed ID: 18220984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments, characteristics and potential applications of screen-printed electrodes in pharmaceutical and biological analysis.
    Couto RA; Lima JL; Quinaz MB
    Talanta; 2016 Jan; 146():801-14. PubMed ID: 26695333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in microfluidics for drug discovery.
    Lombardi D; Dittrich PS
    Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrochemical oxidation by square-wave potential pulses in the imitation of phenacetin to acetaminophen biotransformation.
    Nouri-Nigjeh E; Bischoff R; Bruins AP; Permentier HP
    Analyst; 2011 Dec; 136(23):5064-7. PubMed ID: 21984979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High throughput screening methodologies classified for major drug target classes according to target signaling pathways.
    Kool J; Lingeman H; Niessen W; Irth H
    Comb Chem High Throughput Screen; 2010 Jul; 13(6):548-61. PubMed ID: 20429869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High throughput technologies in drug discovery.
    Kundu B
    Comb Chem High Throughput Screen; 2011 Dec; 14(10):829. PubMed ID: 21843140
    [No Abstract]   [Full Text] [Related]  

  • 33. Toward high-throughput drug screening on a chip-based parallel affinity separation platform.
    Ohlson S; Duong-Thi MD; Bergström M; Fex T; Hansson L; Pedersen L; Guazotti S; Isaksson R
    J Sep Sci; 2010 Sep; 33(17-18):2575-81. PubMed ID: 20730836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Label-free screening assays: a strategy for finding better drug candidates.
    Lunn CA
    Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions.
    Vuignier K; Guillarme D; Veuthey JL; Carrupt PA; Schappler J
    J Pharm Biomed Anal; 2013 Feb; 74():205-12. PubMed ID: 23245252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.
    Duffy BC; Zhu L; Decornez H; Kitchen DB
    Bioorg Med Chem; 2012 Sep; 20(18):5324-42. PubMed ID: 22938785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds.
    Hillard EA; de Abreu FC; Ferreira DC; Jaouen G; Goulart MO; Amatore C
    Chem Commun (Camb); 2008 Jun; (23):2612-28. PubMed ID: 18535688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual screening in drug design and development.
    Sousa SF; Cerqueira NM; Fernandes PA; Ramos MJ
    Comb Chem High Throughput Screen; 2010 Jun; 13(5):442-53. PubMed ID: 20236061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma protein binding in drug discovery and development.
    Howard ML; Hill JJ; Galluppi GR; McLean MA
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):170-87. PubMed ID: 20053162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.